BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25688877)

  • 1. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
    John A; Kizhakkedath P; Al-Gazali L; Ali BR
    Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.
    Fu LJ; Zhou AQ; Huang MR; Shen SH; Shen J; Zhang ZF; Li F
    Chin Med J (Engl); 2008 Mar; 121(5):399-404. PubMed ID: 18364108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
    Prewitt AR; Ghose S; Frump AL; Datta A; Austin ED; Kenworthy AK; de Caestecker MP
    J Biol Chem; 2015 Jan; 290(2):960-71. PubMed ID: 25411245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
    Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue.
    Sobolewski A; Rudarakanchana N; Upton PD; Yang J; Crilley TK; Trembath RC; Morrell NW
    Hum Mol Genet; 2008 Oct; 17(20):3180-90. PubMed ID: 18647753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension.
    Li W; Dunmore BJ; Morrell NW
    Proc Am Thorac Soc; 2010 Nov; 7(6):395-8. PubMed ID: 21030519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.
    Ihida-Stansbury K; McKean DM; Lane KB; Loyd JE; Wheeler LA; Morrell NW; Jones PL
    Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L694-702. PubMed ID: 16782755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
    Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
    PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the cellular mechanisms that modulate trafficking of frizzled family receptor 4 (FZD4) missense mutants associated with familial exudative vitreoretinopathy.
    Milhem RM; Ben-Salem S; Al-Gazali L; Ali BR
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(6):3423-31. PubMed ID: 24744206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
    Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.
    Rejon CA; Hancock MA; Li YN; Thompson TB; Hébert TE; Bernard DJ
    Cell Signal; 2013 Dec; 25(12):2717-26. PubMed ID: 24018044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele.
    Hamid R; Cogan JD; Hedges LK; Austin E; Phillips JA; Newman JH; Loyd JE
    Hum Mutat; 2009 Apr; 30(4):649-54. PubMed ID: 19206171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension.
    Frump AL; Lowery JW; Hamid R; Austin ED; de Caestecker M
    PLoS One; 2013; 8(11):e80319. PubMed ID: 24224048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo mutations in the BMPR2 gene in patients with heritable pulmonary arterial hypertension.
    Momose Y; Aimi Y; Hirayama T; Kataoka M; Ono M; Yoshino H; Satoh T; Gamou S
    Ann Hum Genet; 2015 Mar; 79(2):85-91. PubMed ID: 25612240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.